Aytu BioScience Inc. [NASDAQ: AYTU] loss -3.38% on the last trading session, reaching $1.43 price per share at the time. Aytu BioScience Inc. represents 35.28 million in outstanding shares, while the company has a total market value of $128.31 million with the latest information. AYTU stock price has been found in the range of $1.41 to $1.47.
If compared to the average trading volume of 24.66M shares, AYTU reached a trading volume of 7408597 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Here is what top equities market gurus are saying about Aytu BioScience Inc. [AYTU]:
H.C. Wainwright have made an estimate for Aytu BioScience Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 29, 2020.
The Average True Range (ATR) for Aytu BioScience Inc. is set at 0.11, with the Price to Sales ratio for AYTU stock in the period of the last 12 months amounting to 8.85. The Price to Book ratio for the last quarter was 0.59, with the Price to Cash per share for the same quarter was set at 0.69.
Trading performance analysis for AYTU stock
Aytu BioScience Inc. [AYTU] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.05. With this latest performance, AYTU shares dropped by -11.73% in over the last four-week period, additionally plugging by 106.95% over the last 6 months – not to mention a drop of -20.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AYTU stock in for the last two-week period is set at 44.85, with the RSI for the last a single of trading hit 41.84, and the three-weeks RSI is set at 47.98 for Aytu BioScience Inc. [AYTU]. The present Moving Average for the last 50 days of trading for this stock 1.5175, while it was recorded at 1.4640 for the last single week of trading, and 1.1504 for the last 200 days.
Aytu BioScience Inc. [AYTU]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aytu BioScience Inc. [AYTU] shares currently have an operating margin of -222.35 and a Gross Margin at +40.74. Aytu BioScience Inc.’s Net Margin is presently recorded at -370.64.
Return on Total Capital for AYTU is now -158.70, given the latest momentum, and Return on Invested Capital for the company is -264.54. Return on Equity for this stock declined to -264.54, with Return on Assets sitting at -97.28.
Reflecting on the efficiency of the workforce at the company, Aytu BioScience Inc. [AYTU] managed to generate an average of -$511,923 per employee. Receivables Turnover for the company is 6.31 with a Total Asset Turnover recorded at a value of 0.26.Aytu BioScience Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 2.00.
Aytu BioScience Inc. [AYTU]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Aytu BioScience Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.33/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AYTU.
An analysis of insider ownership at Aytu BioScience Inc. [AYTU]
There are presently around $3 million, or 8.80% of AYTU stock, in the hands of institutional investors. The top three institutional holders of AYTU stocks are: VANGUARD GROUP INC with ownership of 571,383, which is approximately 499.758% of the company’s market cap and around 11.30% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 305,600 shares of the stock with an approximate value of $0.45 million in AYTU stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $0.36 million in AYTU stock with ownership of nearly New of the company’s market capitalization.
Positions in Aytu BioScience Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 33 institutional holders increased their position in Aytu BioScience Inc. [NASDAQ:AYTU] by around 1,659,398 shares. Additionally, 8 investors decreased positions by around 8,134,080 shares, while 6 investors held positions by with 7,778,752 shares. The mentioned changes placed institutional holdings at 2,014,726 shares, according to the latest SEC report filing. AYTU stock had 25 new institutional investments in for a total of 1,069,422 shares, while 6 institutional investors sold positions of 7,979,891 shares during the same period.